Osteopontin: a potentially important therapeutic target in cancer.
about
Diagnostic value of osteopontin in ovarian cancer: a meta-analysis and systematic reviewThe combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory studyPrognostic value of secreted phosphoprotein-1 in pleural effusion associated with non-small cell lung cancerChanges in the transcriptional profile in response to overexpression of the osteopontin-c splice isoform in ovarian (OvCar-3) and prostate (PC-3) cancer cell lines.Osteopontin upregulates the expression of glucose transporters in osteosarcoma cells.Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver.Functional characterization of stromal osteopontin in melanoma progression and metastasis.Inhibitory effect of ethanol extract of Ocimum sanctum on osteopontin mediated metastasis of NCI-H460 non-small cell lung cancer cells.Osteopontin Potentiates Pulmonary Inflammation and Fibrosis by Modulating IL-17/IFN-γ-secreting T-cell Ratios in Bleomycin-treated MiceOsteopontin and thrombospondin-1 play opposite roles in promoting tumor aggressiveness of primary resected non-small cell lung cancer.Prognostic significance of osteopontin in patients with non-small cell lung cancer: results from a meta-analysis.Matricellular proteins in drug delivery: Therapeutic targets, active agents, and therapeutic localizationSerum osteopontin and tissue inhibitor of metalloproteinase 1 as diagnostic and prognostic biomarkers for pancreatic adenocarcinomaFunctional assessment of glioma pathogenesis by in vivo multi-parametric magnetic resonance imaging and in vitro analyses.Plasma osteopontin is a useful diagnostic biomarker for advanced non-small cell lung cancer.Association of osteopontin and cyclooxygenase-2 expression with breast cancer subtypes and their use as potential biomarkersPhosphoprotein secretome of tumor cells as a source of candidates for breast cancer biomarkers in plasma.Gene expression profiling in bladder cancer identifies potential therapeutic targetsOsteopontin as a therapeutic target for cancer.Ablation of osteopontin suppresses N-methyl-N-nitrosourea and Helicobacter pylori-induced gastric cancer development in mice.Evaluation of copy number variation and gene expression in neurofibromatosis type-1-associated malignant peripheral nerve sheath tumours.Targeting osteopontin suppresses glioblastoma stem-like cell character and tumorigenicity in vivo.Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.Osteopontin expressions correlate with WHO grades and predict recurrence in meningiomas.An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis SuppressionBiological markers of prognosis, response to therapy and outcome in ovarian carcinoma.Tertiary structure prediction and identification of druggable pocket in the cancer biomarker - Osteopontin-c.Osteopontin is involved in TLR4 pathway contributing to ovarian cancer cell proliferation and metastasis.Epoxyazadiradione suppresses breast tumor growth through mitochondrial depolarization and caspase-dependent apoptosis by targeting PI3K/Akt pathway.The Rho GTPase signalling pathway in urothelial carcinoma.Deficient TSC1/TSC2-complex suppression of SOX9-osteopontin-AKT signalling cascade constrains tumour growth in tuberous sclerosis complex.Evaluation of osteopontin as a potential biomarker for central nervous system embryonal tumors.Osteopontin as a discriminating marker for pancreatic cancer and chronic pancreatitis.The Biology and Therapeutic Implications of Tumor Dormancy and Reactivation.SPP1 promotes ovarian cancer progression via Integrin β1/FAK/AKT signaling pathway.[SIBLING proteins: molecular tools for tumor progression and angiogenesis].Osteopontin promotes cancer cell drug resistance, invasion, and lactate production and is associated with poor outcome of patients with advanced non-small-cell lung cancerThe Role of Mediators of Cell Invasiveness, Motility, and Migration in the Pathogenesis of Silent Corticotroph Adenomas
P2860
Q28082845-F179943B-5FF3-4318-BDE7-BFE89E992BE9Q28388750-5CEC9858-2855-4E98-9D89-C6B5C5E42DABQ33584942-996D7386-18CC-4D5E-A1BC-C719E274E1ECQ33823827-D4F217CB-200E-473E-982A-6AE9BFD8EA9FQ34332053-AD89B29A-1A73-44D1-8CE1-15D44788A602Q34469107-80303633-A730-445A-B48D-FB848E587C07Q34919176-499D87F4-F288-48E8-90CD-D0E48FC69C00Q35366515-917E2874-456A-481B-A8AB-0B0B1CAE9B3EQ35802597-65B974C4-013A-479F-9B6C-691B3C91CA90Q36079101-2863986E-CBA1-418C-A848-B16CD34BB070Q36182815-8545A467-8064-41F1-8F17-FFA391843EEEQ36578825-BAFE7B4E-6875-41F4-A21B-ABDBACC89930Q36622740-F3F444F7-DFB6-4709-AEE0-9F140DE34B93Q36919071-F3B25906-6479-4B0A-8AFA-6FF122615024Q37213965-EECC7573-8025-4E5C-B56C-4D725929FE0FQ37326197-3143E2D6-C9C4-46DE-B967-ABA61DA14308Q37687414-08074220-D940-4C09-9C80-C32428A19CD0Q37718676-E175FF11-3315-40B0-A0B3-5D3A5653C75FQ38217758-ED608AF1-D4B2-40B6-AF1E-298C7C02AF02Q38830146-1CBE995F-1B57-4108-AB25-501B1F5BEB32Q38885862-07AFB300-A6FC-4085-965F-01EA1F2084F7Q38916554-C8E3DB96-FDD7-4617-9157-C69DBCE46F9EQ39144797-789CB3D4-EE11-477D-8A88-B2C16866E199Q39398193-9097CF51-BC43-4277-89A3-AC5478C6E6D8Q39424176-9DAA6538-7C38-4357-82B6-4C958ED2EC62Q41006936-4FAD6247-B363-4FAD-A619-FE7B1612877DQ41951757-2468AD92-C71C-4171-BFC7-E0B50AFF4DE6Q47143392-6B15C609-30B2-4663-9727-1F72CAFEBF20Q47196315-8DEBF002-D041-4634-8AB5-D5BB4610D950Q47406507-006DCA24-AF45-4722-B7E9-D4780E98BB2CQ48011957-C566A7C1-A817-4C59-9A79-3F713E14F08CQ50675758-10405056-8A97-4600-B0D8-F6F499D7A627Q51697993-1C49F8E6-1365-4A43-99F1-74694DC3B780Q52608415-A33B7D4E-E972-4929-98B8-50E3B986082DQ54120290-F932C4E0-9834-4909-B103-C129E26D08A9Q54530705-97BAFBB7-C995-4806-A436-C387BA0FFE7AQ57073431-156F69A8-FE38-4551-B241-B99E937EF203Q57793970-D04941DA-B793-419E-912F-26C7669184F1
P2860
Osteopontin: a potentially important therapeutic target in cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 July 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Osteopontin: a potentially important therapeutic target in cancer.
@en
Osteopontin: a potentially important therapeutic target in cancer.
@nl
type
label
Osteopontin: a potentially important therapeutic target in cancer.
@en
Osteopontin: a potentially important therapeutic target in cancer.
@nl
prefLabel
Osteopontin: a potentially important therapeutic target in cancer.
@en
Osteopontin: a potentially important therapeutic target in cancer.
@nl
P2093
P2860
P50
P1476
Osteopontin: a potentially important therapeutic target in cancer.
@en
P2093
Anuja Ramdasi
Anuradha Bulbule
Dhanashri Thorat
Goutam Chakraborty
Gowrishankar Soundararajan
Mansoor Ahmed
Megha Sanyal
Pompom Ghosh
Priyanka Sharma
Rajinder Kaur
P2860
P304
P356
10.1517/14728222.2011.594438
P407
P577
2011-07-25T00:00:00Z